CME Group Inc. (NASDAQ:CME) Shares Purchased by Sumitomo Mitsui Trust Group Inc.

Sumitomo Mitsui Trust Group Inc. grew its stake in shares of CME Group Inc. (NASDAQ:CME) by 0.9% in the third quarter, HoldingsChannel reports. The fund owned 958,085 shares of the financial services provider’s stock after buying an additional 8,561 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in CME Group were worth $211,401,000 at the end of the most recent quarter.

Several other large investors have also modified their holdings of the stock. Empowered Funds LLC grew its position in CME Group by 24.5% during the first quarter. Empowered Funds LLC now owns 5,596 shares of the financial services provider’s stock valued at $1,205,000 after acquiring an additional 1,101 shares during the period. Avantax Advisory Services Inc. grew its holdings in shares of CME Group by 4.5% during the 1st quarter. Avantax Advisory Services Inc. now owns 7,415 shares of the financial services provider’s stock worth $1,596,000 after purchasing an additional 318 shares during the period. Edmond DE Rothschild Holding S.A. increased its position in CME Group by 102.1% during the 1st quarter. Edmond DE Rothschild Holding S.A. now owns 4,741 shares of the financial services provider’s stock worth $1,021,000 after purchasing an additional 2,395 shares in the last quarter. Entropy Technologies LP purchased a new position in CME Group in the first quarter valued at approximately $730,000. Finally, Koshinski Asset Management Inc. acquired a new position in CME Group during the first quarter valued at approximately $244,000. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

CME Group Stock Up 0.2 %

NASDAQ:CME opened at $226.31 on Wednesday. The company has a debt-to-equity ratio of 0.09, a quick ratio of 1.02 and a current ratio of 1.02. The company has a market capitalization of $81.49 billion, a price-to-earnings ratio of 23.80, a price-to-earnings-growth ratio of 5.68 and a beta of 0.55. CME Group Inc. has a one year low of $190.70 and a one year high of $230.36. The stock has a 50-day simple moving average of $221.92 and a 200 day simple moving average of $209.93.

CME Group (NASDAQ:CME) last issued its earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business’s revenue was up 18.4% on a year-over-year basis. During the same quarter last year, the firm earned $2.25 EPS. Sell-side analysts predict that CME Group Inc. will post 10.23 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Shareholders of record on Monday, December 9th will be issued a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, December 9th. This represents a $4.60 dividend on an annualized basis and a dividend yield of 2.03%. CME Group’s dividend payout ratio (DPR) is 48.37%.

Analyst Upgrades and Downgrades

CME has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft cut their target price on shares of CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research note on Monday. Barclays upped their target price on CME Group from $219.00 to $231.00 and gave the stock an “equal weight” rating in a research report on Thursday, October 24th. The Goldman Sachs Group raised their target price on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a report on Thursday, October 3rd. Keefe, Bruyette & Woods upped their price target on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Finally, Redburn Atlantic lowered shares of CME Group from a “buy” rating to a “neutral” rating and set a $244.00 price objective on the stock. in a research note on Tuesday, October 8th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat, CME Group presently has an average rating of “Hold” and a consensus target price of $224.47.

Insider Transactions at CME Group

In related news, Director Martin J. Gepsman sold 400 shares of the business’s stock in a transaction dated Monday, November 4th. The shares were sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the sale, the director now owns 25,067 shares of the company’s stock, valued at $5,587,935.64. This represents a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other CME Group news, Director Timothy S. Bitsberger sold 1,000 shares of the firm’s stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $226.96, for a total value of $226,960.00. Following the sale, the director now directly owns 10,589 shares in the company, valued at approximately $2,403,279.44. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Martin J. Gepsman sold 400 shares of the company’s stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the transaction, the director now owns 25,067 shares of the company’s stock, valued at $5,587,935.64. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 15,621 shares of company stock worth $3,441,063. 0.30% of the stock is currently owned by insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.